By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

H. Lundbeck A/S 

Ottiliavej 9

Valby  Copenhagen  DK-2500  Denmark
Phone: 45-3630-1311 Fax: 45 3630 1940


SEARCH JOBS




Collaborations

Forest Laboratories, Inc.  Forest's partner for many of the drug compounds that we develop, manufacture and market in the U.S. for central nervous system disorders, including Lexapro.





Company News
Ossianix Expands And Extends Its Research Collaboration With H. Lundbeck A/S (LUN.CO) On CNS Therapeutics 12/16/2014 10:52:35 AM
Otsuka America Pharmaceutical, Inc. And H. Lundbeck A/S (LUN.CO) Release: U.S. FDA Accepts For Review Supplemental New Drug Application For Deltoid Administration Of Abilify Maintena® (Aripiprazole) Extended-Release Injectable Suspension 12/15/2014 10:13:44 AM
Otsuka Pharmaceutical Co., Ltd. And H. Lundbeck A/S (LUN.CO)’s Brexpiprazole Demonstrates Statistically Significant Effects In New Phase 3 Studies In Adult Patients With Schizophrenia Presented At The American College Of Neuropsychopharmacology Annual Meeting 12/11/2014 7:27:03 AM
Otsuka Pharmaceutical Co., Ltd. And H. Lundbeck A/S (LUN.CO) Present Phase 3 Data On Brexpiprazole As Adjunctive Therapy In Adult Patients With Major Depression At The American College Of Neuropsychopharmacology Annual Meeting 12/10/2014 10:29:43 AM
H. Lundbeck A/S (LUN.CO) Release: New Study: Art Therapy May Build Self-Esteem In People Living With Epilepsy 12/8/2014 10:27:38 AM
H. Lundbeck A/S (LUN.CO) Release: Five-Year Data From SABRIL® (Vigabatrin) Registry Presented At American Epilepsy Society Annual Meeting 12/8/2014 10:26:40 AM
Otsuka America Pharmaceutical, Inc. And H. Lundbeck A/S (LUN.CO) Release: Aripiprazole Once-Monthly Injectable Shows Superior Effectiveness To Paliperidone Palmitate Once-Monthly Injectable On Quality Of Life Scale In Patients With Schizophrenia 11/3/2014 10:57:38 AM
Otsuka Pharmaceutical Co., Ltd. And H. Lundbeck A/S (LUN.CO) Submit New Drug Application In The US For Brexpiprazole For The Treatment Of Schizophrenia And As Adjunctive Therapy For The Treatment Of Major Depressive Disorder 7/14/2014 8:24:21 AM
H. Lundbeck A/S (LUN.CO)'s Late Stage Trials For Stroke Failed To Meet Primary Endpoint 6/27/2014 8:41:52 AM
H. Lundbeck A/S (LUN.CO) Release: New Study Results Demonstrate Brintellix® (Vortioxetine) Is Efficacious In Asian Patients Suffering From Depression 6/26/2014 7:37:21 AM
123456789
//-->